| Name | Title | Contact Details |
|---|
Continucare Corporation is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Continucare Corporation is based in Miami, FL. You can find more information on Continucare Corporation at www.continucare.com
Memorial Hospital and Health Care Center offers a comprehensive range of acute medical services in a 137-bed facility located on Ninth Street in Jasper. As a regional health center with approximately 100 active staff physicians and 1,700 employees, Memorial Hospital serves Dubois and surrounding counties in southern Indiana. Under the sponsorship of the Sisters of the Little Company of Mary, the hospital annually provides care for 6,600 inpatients and 254,000 outpatients. Mission: Christ`s healing mission of compassion empowers us to be for others through quality and excellence. Core Values: Compassionate Caring, Respect for Human Dignity, Quality, Justice, and Stewardship
EmpiRx Health is challenging the status quo in today`s pharmacy benefit management industry by offering evidence-based clinical care programs that are aligned with our member`s needs. Our concierge model along with our proactive oversight and agile technology platform provide actionable insight to protect our clients and their members from ever-rising drug costs.
FOR ALMOST TWO DECADES, MARKWINS INTERNATIONAL has been providing expertly designed cosmetic and beauty care collections.
More than 20,000 genes make us human. Genes control critical aspects of health and disease — but what controls our genes? Foghorn® Therapeutics ($FHTX) is developing therapies based on a system that directs which genes our cells express, and when, where, and in what order. By manipulating this system with our unique Gene Traffic Control™ platform, Foghorn will change how genes turn “on” and “off.” Unlike approaches that edit genes, this novel way of thinking will alter what our DNA has in store for us—and rewrite destiny for millions of people living with disease. With Gene Traffic Control™ Foghorn is pioneering a new, major class of drug targets to develop unprecedented therapies for cancer and other serious diseases. We have already validated multiple targets, are in the process of developing drug candidates in multiple types of cancer and are beginning to explore other diseases.